The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bicyclic Peptide Drugs Market Research Report 2025
Synopsis
The global Bicyclic Peptide Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Bicyclic Peptide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bicyclic Peptide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bicyclic Peptide Drugs include Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Thermo Fisher, ApexBio Technology, BPS Bioscience, Selleck Chemicals, AdooQ BioScience, Cayman Chemical Company, Santa Cruz Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bicyclic Peptide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bicyclic Peptide Drugs.
The Bicyclic Peptide Drugs market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Bicyclic Peptide Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bicyclic Peptide Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bicycle Therapeutics
Apellis Pharmaceuticals
Merck
Thermo Fisher
ApexBio Technology
BPS Bioscience
Selleck Chemicals
AdooQ BioScience
Cayman Chemical Company
Santa Cruz Biotechnology
TargetMol Chemicals
Abcam
Biotium
Cayman Chemical
Apollo Scientific
Tocris Bioscience
Ningbo Inno Pharmchem
Dayang Chemicals
Shanghai Lollane Biological Technology
Dalian Meilun Biotech
Segment by Type
Romidepsin
Phalloidin
Others
Segment by Application
Anti-Cancer
Antibacterial
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bicyclic Peptide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bicyclic Peptide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Bicyclic Peptide Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Bicyclic Peptide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bicyclic Peptide Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bicyclic Peptide Drugs include Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Thermo Fisher, ApexBio Technology, BPS Bioscience, Selleck Chemicals, AdooQ BioScience, Cayman Chemical Company, Santa Cruz Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bicyclic Peptide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bicyclic Peptide Drugs.
The Bicyclic Peptide Drugs market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Bicyclic Peptide Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bicyclic Peptide Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bicycle Therapeutics
Apellis Pharmaceuticals
Merck
Thermo Fisher
ApexBio Technology
BPS Bioscience
Selleck Chemicals
AdooQ BioScience
Cayman Chemical Company
Santa Cruz Biotechnology
TargetMol Chemicals
Abcam
Biotium
Cayman Chemical
Apollo Scientific
Tocris Bioscience
Ningbo Inno Pharmchem
Dayang Chemicals
Shanghai Lollane Biological Technology
Dalian Meilun Biotech
Segment by Type
Romidepsin
Phalloidin
Others
Segment by Application
Anti-Cancer
Antibacterial
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bicyclic Peptide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bicyclic Peptide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bicyclic Peptide Drugs Market Overview
1.1 Product Definition
1.2 Bicyclic Peptide Drugs by Type
1.2.1 Global Bicyclic Peptide Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Romidepsin
1.2.3 Phalloidin
1.2.4 Others
1.3 Bicyclic Peptide Drugs by Application
1.3.1 Global Bicyclic Peptide Drugs Market Value by Application (2024-2030)
1.3.2 Anti-Cancer
1.3.3 Antibacterial
1.3.4 Others
1.4 Global Bicyclic Peptide Drugs Market Size Estimates and Forecasts
1.4.1 Global Bicyclic Peptide Drugs Revenue 2019-2030
1.4.2 Global Bicyclic Peptide Drugs Sales 2019-2030
1.4.3 Global Bicyclic Peptide Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bicyclic Peptide Drugs Market Competition by Manufacturers
2.1 Global Bicyclic Peptide Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bicyclic Peptide Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bicyclic Peptide Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Bicyclic Peptide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bicyclic Peptide Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bicyclic Peptide Drugs, Product Type & Application
2.7 Global Key Manufacturers of Bicyclic Peptide Drugs, Date of Enter into This Industry
2.8 Global Bicyclic Peptide Drugs Market Competitive Situation and Trends
2.8.1 Global Bicyclic Peptide Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bicyclic Peptide Drugs Players Market Share by Revenue
2.8.3 Global Bicyclic Peptide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bicyclic Peptide Drugs Market Scenario by Region
3.1 Global Bicyclic Peptide Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bicyclic Peptide Drugs Sales by Region: 2019-2030
3.2.1 Global Bicyclic Peptide Drugs Sales by Region: 2019-2024
3.2.2 Global Bicyclic Peptide Drugs Sales by Region: 2025-2030
3.3 Global Bicyclic Peptide Drugs Revenue by Region: 2019-2030
3.3.1 Global Bicyclic Peptide Drugs Revenue by Region: 2019-2024
3.3.2 Global Bicyclic Peptide Drugs Revenue by Region: 2025-2030
3.4 North America Bicyclic Peptide Drugs Market Facts & Figures by Country
3.4.1 North America Bicyclic Peptide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bicyclic Peptide Drugs Sales by Country (2019-2030)
3.4.3 North America Bicyclic Peptide Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bicyclic Peptide Drugs Market Facts & Figures by Country
3.5.1 Europe Bicyclic Peptide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bicyclic Peptide Drugs Sales by Country (2019-2030)
3.5.3 Europe Bicyclic Peptide Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bicyclic Peptide Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Bicyclic Peptide Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bicyclic Peptide Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Bicyclic Peptide Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bicyclic Peptide Drugs Market Facts & Figures by Country
3.7.1 Latin America Bicyclic Peptide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bicyclic Peptide Drugs Sales by Country (2019-2030)
3.7.3 Latin America Bicyclic Peptide Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bicyclic Peptide Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Bicyclic Peptide Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bicyclic Peptide Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bicyclic Peptide Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bicyclic Peptide Drugs Sales by Type (2019-2030)
4.1.1 Global Bicyclic Peptide Drugs Sales by Type (2019-2024)
4.1.2 Global Bicyclic Peptide Drugs Sales by Type (2025-2030)
4.1.3 Global Bicyclic Peptide Drugs Sales Market Share by Type (2019-2030)
4.2 Global Bicyclic Peptide Drugs Revenue by Type (2019-2030)
4.2.1 Global Bicyclic Peptide Drugs Revenue by Type (2019-2024)
4.2.2 Global Bicyclic Peptide Drugs Revenue by Type (2025-2030)
4.2.3 Global Bicyclic Peptide Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Bicyclic Peptide Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bicyclic Peptide Drugs Sales by Application (2019-2030)
5.1.1 Global Bicyclic Peptide Drugs Sales by Application (2019-2024)
5.1.2 Global Bicyclic Peptide Drugs Sales by Application (2025-2030)
5.1.3 Global Bicyclic Peptide Drugs Sales Market Share by Application (2019-2030)
5.2 Global Bicyclic Peptide Drugs Revenue by Application (2019-2030)
5.2.1 Global Bicyclic Peptide Drugs Revenue by Application (2019-2024)
5.2.2 Global Bicyclic Peptide Drugs Revenue by Application (2025-2030)
5.2.3 Global Bicyclic Peptide Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Bicyclic Peptide Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bicycle Therapeutics
6.1.1 Bicycle Therapeutics Company Information
6.1.2 Bicycle Therapeutics Description and Business Overview
6.1.3 Bicycle Therapeutics Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bicycle Therapeutics Bicyclic Peptide Drugs Product Portfolio
6.1.5 Bicycle Therapeutics Recent Developments/Updates
6.2 Apellis Pharmaceuticals
6.2.1 Apellis Pharmaceuticals Company Information
6.2.2 Apellis Pharmaceuticals Description and Business Overview
6.2.3 Apellis Pharmaceuticals Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Apellis Pharmaceuticals Bicyclic Peptide Drugs Product Portfolio
6.2.5 Apellis Pharmaceuticals Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Bicyclic Peptide Drugs Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Thermo Fisher
6.4.1 Thermo Fisher Company Information
6.4.2 Thermo Fisher Description and Business Overview
6.4.3 Thermo Fisher Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thermo Fisher Bicyclic Peptide Drugs Product Portfolio
6.4.5 Thermo Fisher Recent Developments/Updates
6.5 ApexBio Technology
6.5.1 ApexBio Technology Company Information
6.5.2 ApexBio Technology Description and Business Overview
6.5.3 ApexBio Technology Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ApexBio Technology Bicyclic Peptide Drugs Product Portfolio
6.5.5 ApexBio Technology Recent Developments/Updates
6.6 BPS Bioscience
6.6.1 BPS Bioscience Company Information
6.6.2 BPS Bioscience Description and Business Overview
6.6.3 BPS Bioscience Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BPS Bioscience Bicyclic Peptide Drugs Product Portfolio
6.6.5 BPS Bioscience Recent Developments/Updates
6.7 Selleck Chemicals
6.7.1 Selleck Chemicals Company Information
6.7.2 Selleck Chemicals Description and Business Overview
6.7.3 Selleck Chemicals Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Selleck Chemicals Bicyclic Peptide Drugs Product Portfolio
6.7.5 Selleck Chemicals Recent Developments/Updates
6.8 AdooQ BioScience
6.8.1 AdooQ BioScience Company Information
6.8.2 AdooQ BioScience Description and Business Overview
6.8.3 AdooQ BioScience Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AdooQ BioScience Bicyclic Peptide Drugs Product Portfolio
6.8.5 AdooQ BioScience Recent Developments/Updates
6.9 Cayman Chemical Company
6.9.1 Cayman Chemical Company Company Information
6.9.2 Cayman Chemical Company Description and Business Overview
6.9.3 Cayman Chemical Company Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cayman Chemical Company Bicyclic Peptide Drugs Product Portfolio
6.9.5 Cayman Chemical Company Recent Developments/Updates
6.10 Santa Cruz Biotechnology
6.10.1 Santa Cruz Biotechnology Company Information
6.10.2 Santa Cruz Biotechnology Description and Business Overview
6.10.3 Santa Cruz Biotechnology Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Santa Cruz Biotechnology Bicyclic Peptide Drugs Product Portfolio
6.10.5 Santa Cruz Biotechnology Recent Developments/Updates
6.11 TargetMol Chemicals
6.11.1 TargetMol Chemicals Company Information
6.11.2 TargetMol Chemicals Description and Business Overview
6.11.3 TargetMol Chemicals Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 TargetMol Chemicals Bicyclic Peptide Drugs Product Portfolio
6.11.5 TargetMol Chemicals Recent Developments/Updates
6.12 Abcam
6.12.1 Abcam Company Information
6.12.2 Abcam Description and Business Overview
6.12.3 Abcam Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abcam Bicyclic Peptide Drugs Product Portfolio
6.12.5 Abcam Recent Developments/Updates
6.13 Biotium
6.13.1 Biotium Company Information
6.13.2 Biotium Description and Business Overview
6.13.3 Biotium Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Biotium Bicyclic Peptide Drugs Product Portfolio
6.13.5 Biotium Recent Developments/Updates
6.14 Cayman Chemical
6.14.1 Cayman Chemical Company Information
6.14.2 Cayman Chemical Description and Business Overview
6.14.3 Cayman Chemical Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Cayman Chemical Bicyclic Peptide Drugs Product Portfolio
6.14.5 Cayman Chemical Recent Developments/Updates
6.15 Apollo Scientific
6.15.1 Apollo Scientific Company Information
6.15.2 Apollo Scientific Description and Business Overview
6.15.3 Apollo Scientific Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Apollo Scientific Bicyclic Peptide Drugs Product Portfolio
6.15.5 Apollo Scientific Recent Developments/Updates
6.16 Tocris Bioscience
6.16.1 Tocris Bioscience Company Information
6.16.2 Tocris Bioscience Description and Business Overview
6.16.3 Tocris Bioscience Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Tocris Bioscience Bicyclic Peptide Drugs Product Portfolio
6.16.5 Tocris Bioscience Recent Developments/Updates
6.17 Ningbo Inno Pharmchem
6.17.1 Ningbo Inno Pharmchem Company Information
6.17.2 Ningbo Inno Pharmchem Description and Business Overview
6.17.3 Ningbo Inno Pharmchem Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Ningbo Inno Pharmchem Bicyclic Peptide Drugs Product Portfolio
6.17.5 Ningbo Inno Pharmchem Recent Developments/Updates
6.18 Dayang Chemicals
6.18.1 Dayang Chemicals Company Information
6.18.2 Dayang Chemicals Description and Business Overview
6.18.3 Dayang Chemicals Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Dayang Chemicals Bicyclic Peptide Drugs Product Portfolio
6.18.5 Dayang Chemicals Recent Developments/Updates
6.19 Shanghai Lollane Biological Technology
6.19.1 Shanghai Lollane Biological Technology Company Information
6.19.2 Shanghai Lollane Biological Technology Description and Business Overview
6.19.3 Shanghai Lollane Biological Technology Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Shanghai Lollane Biological Technology Bicyclic Peptide Drugs Product Portfolio
6.19.5 Shanghai Lollane Biological Technology Recent Developments/Updates
6.20 Dalian Meilun Biotech
6.20.1 Dalian Meilun Biotech Company Information
6.20.2 Dalian Meilun Biotech Description and Business Overview
6.20.3 Dalian Meilun Biotech Bicyclic Peptide Drugs Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Dalian Meilun Biotech Bicyclic Peptide Drugs Product Portfolio
6.20.5 Dalian Meilun Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bicyclic Peptide Drugs Industry Chain Analysis
7.2 Bicyclic Peptide Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bicyclic Peptide Drugs Production Mode & Process
7.4 Bicyclic Peptide Drugs Sales and Marketing
7.4.1 Bicyclic Peptide Drugs Sales Channels
7.4.2 Bicyclic Peptide Drugs Distributors
7.5 Bicyclic Peptide Drugs Customers
8 Bicyclic Peptide Drugs Market Dynamics
8.1 Bicyclic Peptide Drugs Industry Trends
8.2 Bicyclic Peptide Drugs Market Drivers
8.3 Bicyclic Peptide Drugs Market Challenges
8.4 Bicyclic Peptide Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Bicyclic Peptide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Bicyclic Peptide Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Bicyclic Peptide Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Bicyclic Peptide Drugs Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Bicyclic Peptide Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Bicyclic Peptide Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Bicyclic Peptide Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Bicyclic Peptide Drugs Average Price (US$/kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Bicyclic Peptide Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bicyclic Peptide Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bicyclic Peptide Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Bicyclic Peptide Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bicyclic Peptide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bicyclic Peptide Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bicyclic Peptide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Bicyclic Peptide Drugs Sales by Region (2019-2024) & (Tons)
Table 18. Global Bicyclic Peptide Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Bicyclic Peptide Drugs Sales by Region (2025-2030) & (Tons)
Table 20. Global Bicyclic Peptide Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Bicyclic Peptide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Bicyclic Peptide Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Bicyclic Peptide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Bicyclic Peptide Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Bicyclic Peptide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Bicyclic Peptide Drugs Sales by Country (2019-2024) & (Tons)
Table 27. North America Bicyclic Peptide Drugs Sales by Country (2025-2030) & (Tons)
Table 28. North America Bicyclic Peptide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Bicyclic Peptide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Bicyclic Peptide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Bicyclic Peptide Drugs Sales by Country (2019-2024) & (Tons)
Table 32. Europe Bicyclic Peptide Drugs Sales by Country (2025-2030) & (Tons)
Table 33. Europe Bicyclic Peptide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Bicyclic Peptide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Bicyclic Peptide Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Bicyclic Peptide Drugs Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Bicyclic Peptide Drugs Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Bicyclic Peptide Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Bicyclic Peptide Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Bicyclic Peptide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Bicyclic Peptide Drugs Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Bicyclic Peptide Drugs Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Bicyclic Peptide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Bicyclic Peptide Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Bicyclic Peptide Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Bicyclic Peptide Drugs Sales by Country (2019-2024) & (Tons)
Table 47. Middle East and Africa Bicyclic Peptide Drugs Sales by Country (2025-2030) & (Tons)
Table 48. Middle East and Africa Bicyclic Peptide Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Bicyclic Peptide Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Bicyclic Peptide Drugs Sales (Tons) by Type (2019-2024)
Table 51. Global Bicyclic Peptide Drugs Sales (Tons) by Type (2025-2030)
Table 52. Global Bicyclic Peptide Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Bicyclic Peptide Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Bicyclic Peptide Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Bicyclic Peptide Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Bicyclic Peptide Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Bicyclic Peptide Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Bicyclic Peptide Drugs Price (US$/kg) by Type (2019-2024)
Table 59. Global Bicyclic Peptide Drugs Price (US$/kg) by Type (2025-2030)
Table 60. Global Bicyclic Peptide Drugs Sales (Tons) by Application (2019-2024)
Table 61. Global Bicyclic Peptide Drugs Sales (Tons) by Application (2025-2030)
Table 62. Global Bicyclic Peptide Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Bicyclic Peptide Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Bicyclic Peptide Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Bicyclic Peptide Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Bicyclic Peptide Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Bicyclic Peptide Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Bicyclic Peptide Drugs Price (US$/kg) by Application (2019-2024)
Table 69. Global Bicyclic Peptide Drugs Price (US$/kg) by Application (2025-2030)
Table 70. Bicycle Therapeutics Company Information
Table 71. Bicycle Therapeutics Description and Business Overview
Table 72. Bicycle Therapeutics Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 73. Bicycle Therapeutics Bicyclic Peptide Drugs Product
Table 74. Bicycle Therapeutics Recent Developments/Updates
Table 75. Apellis Pharmaceuticals Company Information
Table 76. Apellis Pharmaceuticals Description and Business Overview
Table 77. Apellis Pharmaceuticals Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 78. Apellis Pharmaceuticals Bicyclic Peptide Drugs Product
Table 79. Apellis Pharmaceuticals Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 83. Merck Bicyclic Peptide Drugs Product
Table 84. Merck Recent Developments/Updates
Table 85. Thermo Fisher Company Information
Table 86. Thermo Fisher Description and Business Overview
Table 87. Thermo Fisher Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 88. Thermo Fisher Bicyclic Peptide Drugs Product
Table 89. Thermo Fisher Recent Developments/Updates
Table 90. ApexBio Technology Company Information
Table 91. ApexBio Technology Description and Business Overview
Table 92. ApexBio Technology Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 93. ApexBio Technology Bicyclic Peptide Drugs Product
Table 94. ApexBio Technology Recent Developments/Updates
Table 95. BPS Bioscience Company Information
Table 96. BPS Bioscience Description and Business Overview
Table 97. BPS Bioscience Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 98. BPS Bioscience Bicyclic Peptide Drugs Product
Table 99. BPS Bioscience Recent Developments/Updates
Table 100. Selleck Chemicals Company Information
Table 101. Selleck Chemicals Description and Business Overview
Table 102. Selleck Chemicals Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 103. Selleck Chemicals Bicyclic Peptide Drugs Product
Table 104. Selleck Chemicals Recent Developments/Updates
Table 105. AdooQ BioScience Company Information
Table 106. AdooQ BioScience Description and Business Overview
Table 107. AdooQ BioScience Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 108. AdooQ BioScience Bicyclic Peptide Drugs Product
Table 109. AdooQ BioScience Recent Developments/Updates
Table 110. Cayman Chemical Company Company Information
Table 111. Cayman Chemical Company Description and Business Overview
Table 112. Cayman Chemical Company Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 113. Cayman Chemical Company Bicyclic Peptide Drugs Product
Table 114. Cayman Chemical Company Recent Developments/Updates
Table 115. Santa Cruz Biotechnology Company Information
Table 116. Santa Cruz Biotechnology Description and Business Overview
Table 117. Santa Cruz Biotechnology Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 118. Santa Cruz Biotechnology Bicyclic Peptide Drugs Product
Table 119. Santa Cruz Biotechnology Recent Developments/Updates
Table 120. TargetMol Chemicals Company Information
Table 121. TargetMol Chemicals Description and Business Overview
Table 122. TargetMol Chemicals Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 123. TargetMol Chemicals Bicyclic Peptide Drugs Product
Table 124. TargetMol Chemicals Recent Developments/Updates
Table 125. Abcam Company Information
Table 126. Abcam Description and Business Overview
Table 127. Abcam Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 128. Abcam Bicyclic Peptide Drugs Product
Table 129. Abcam Recent Developments/Updates
Table 130. Biotium Company Information
Table 131. Biotium Description and Business Overview
Table 132. Biotium Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 133. Biotium Bicyclic Peptide Drugs Product
Table 134. Biotium Recent Developments/Updates
Table 135. Cayman Chemical Company Information
Table 136. Cayman Chemical Description and Business Overview
Table 137. Cayman Chemical Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 138. Cayman Chemical Bicyclic Peptide Drugs Product
Table 139. Cayman Chemical Recent Developments/Updates
Table 140. Apollo Scientific Company Information
Table 141. Apollo Scientific Description and Business Overview
Table 142. Apollo Scientific Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 143. Apollo Scientific Bicyclic Peptide Drugs Product
Table 144. Apollo Scientific Recent Developments/Updates
Table 145. Tocris Bioscience Company Information
Table 146. Tocris Bioscience Description and Business Overview
Table 147. Tocris Bioscience Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 148. Tocris Bioscience Bicyclic Peptide Drugs Product
Table 149. Tocris Bioscience Recent Developments/Updates
Table 150. Ningbo Inno Pharmchem Company Information
Table 151. Ningbo Inno Pharmchem Description and Business Overview
Table 152. Ningbo Inno Pharmchem Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 153. Ningbo Inno Pharmchem Bicyclic Peptide Drugs Product
Table 154. Ningbo Inno Pharmchem Recent Developments/Updates
Table 155. Dayang Chemicals Company Information
Table 156. Dayang Chemicals Description and Business Overview
Table 157. Dayang Chemicals Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 158. Dayang Chemicals Bicyclic Peptide Drugs Product
Table 159. Dayang Chemicals Recent Developments/Updates
Table 160. Shanghai Lollane Biological Technology Company Information
Table 161. Shanghai Lollane Biological Technology Description and Business Overview
Table 162. Shanghai Lollane Biological Technology Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 163. Shanghai Lollane Biological Technology Bicyclic Peptide Drugs Product
Table 164. Shanghai Lollane Biological Technology Recent Developments/Updates
Table 165. Dalian Meilun Biotech Company Information
Table 166. Dalian Meilun Biotech Description and Business Overview
Table 167. Dalian Meilun Biotech Bicyclic Peptide Drugs Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 168. Dalian Meilun Biotech Bicyclic Peptide Drugs Product
Table 169. Dalian Meilun Biotech Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Bicyclic Peptide Drugs Distributors List
Table 173. Bicyclic Peptide Drugs Customers List
Table 174. Bicyclic Peptide Drugs Market Trends
Table 175. Bicyclic Peptide Drugs Market Drivers
Table 176. Bicyclic Peptide Drugs Market Challenges
Table 177. Bicyclic Peptide Drugs Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bicyclic Peptide Drugs
Figure 2. Global Bicyclic Peptide Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Bicyclic Peptide Drugs Market Share by Type: 2023 & 2030
Figure 4. Romidepsin Product Picture
Figure 5. Phalloidin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Bicyclic Peptide Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Bicyclic Peptide Drugs Market Share by Application: 2023 & 2030
Figure 9. Anti-Cancer
Figure 10. Antibacterial
Figure 11. Others
Figure 12. Global Bicyclic Peptide Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Bicyclic Peptide Drugs Market Size (2019-2030) & (US$ Million)
Figure 14. Global Bicyclic Peptide Drugs Sales (2019-2030) & (Tons)
Figure 15. Global Bicyclic Peptide Drugs Average Price (US$/kg) & (2019-2030)
Figure 16. Bicyclic Peptide Drugs Report Years Considered
Figure 17. Bicyclic Peptide Drugs Sales Share by Manufacturers in 2023
Figure 18. Global Bicyclic Peptide Drugs Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Bicyclic Peptide Drugs Players: Market Share by Revenue in Bicyclic Peptide Drugs in 2023
Figure 20. Bicyclic Peptide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Bicyclic Peptide Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Bicyclic Peptide Drugs Sales Market Share by Country (2019-2030)
Figure 23. North America Bicyclic Peptide Drugs Revenue Market Share by Country (2019-2030)
Figure 24. United States Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Bicyclic Peptide Drugs Sales Market Share by Country (2019-2030)
Figure 27. Europe Bicyclic Peptide Drugs Revenue Market Share by Country (2019-2030)
Figure 28. Germany Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Bicyclic Peptide Drugs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Bicyclic Peptide Drugs Revenue Market Share by Region (2019-2030)
Figure 35. China Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Bicyclic Peptide Drugs Sales Market Share by Country (2019-2030)
Figure 43. Mexico Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Bicyclic Peptide Drugs Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Bicyclic Peptide Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Bicyclic Peptide Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Bicyclic Peptide Drugs by Type (2019-2030)
Figure 53. Global Revenue Market Share of Bicyclic Peptide Drugs by Type (2019-2030)
Figure 54. Global Bicyclic Peptide Drugs Price (US$/kg) by Type (2019-2030)
Figure 55. Global Sales Market Share of Bicyclic Peptide Drugs by Application (2019-2030)
Figure 56. Global Revenue Market Share of Bicyclic Peptide Drugs by Application (2019-2030)
Figure 57. Global Bicyclic Peptide Drugs Price (US$/kg) by Application (2019-2030)
Figure 58. Bicyclic Peptide Drugs Value Chain
Figure 59. Bicyclic Peptide Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
